Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-14

Clinical Trial Update: A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a new drug to placebo and an existing Type 2 diabetes treatment has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Existing treatment for Type 2 diabetes
  • New Drug

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2021-04-14